University Of Leipzig
Clinical trials sponsored by University Of Leipzig, explained in plain language.
-
Immunotherapy boost may help prevent head and neck cancer return
Disease control CompletedThis study tested whether adding the immunotherapy drug pembrolizumab to standard chemoradiation after surgery helps prevent cancer from coming back in people with advanced head and neck cancer. About 211 participants who had their tumor completely removed were randomly assigned …
Phase: PHASE2 • Sponsor: University of Leipzig • Aim: Disease control
Last updated May 17, 2026 05:52 UTC
-
New MRI test may detect rare heart disease without a biopsy
Diagnosis CompletedThis study tested a special heart MRI technique called T1 mapping to see if it can accurately diagnose cardiac amyloidosis, a condition where abnormal proteins build up in the heart. Researchers studied 112 older adults with heart failure and thickened heart walls. The goal was t…
Sponsor: University of Leipzig • Aim: Diagnosis
Last updated May 13, 2026 16:01 UTC
-
3D tech shortens kidney surgery time in major trial
Symptom relief CompletedThis study tested whether using a 3D model of a patient's kidney before surgery helps surgeons perform robotic-assisted tumor removal more quickly and safely. 370 adults with small kidney tumors took part. The goal was to see if the 3D model reduces time in surgery and improves o…
Phase: NA • Sponsor: University of Leipzig • Aim: Symptom relief
Last updated May 17, 2026 06:13 UTC
-
Heart failure patients try rehab at home in new pilot study
Symptom relief CompletedThis study tested whether a 12-week home exercise program is practical for people with chronic heart failure who were recently hospitalized. Thirty participants received in-person training and follow-up visits. The goal was to see how many completed the program and whether it imp…
Phase: NA • Sponsor: University of Leipzig • Aim: Symptom relief
Last updated May 15, 2026 11:57 UTC
-
Brain bleed recovery: can doctors beat the odds?
Knowledge-focused CompletedThis study looked at whether doctors, nurses, or standard risk scores are better at predicting long-term recovery in people with a brain hemorrhage. Over 1,000 patients were followed for six months. The goal was to improve how we estimate outcomes and guide treatment decisions.
Sponsor: University of Leipzig • Aim: Knowledge-focused
Last updated May 17, 2026 05:54 UTC
-
Heart Drug's hidden powers revealed: study probes how Sacubitril-Valsartan boosts pumping
Knowledge-focused CompletedThis study looked at how Sacubitril-Valsartan, a medicine for heart failure, helps the heart pump better. Researchers measured heart function in 117 adults with weak hearts using a non-invasive method. The goal was to understand the underlying mechanisms behind the drug's benefit…
Sponsor: University of Leipzig • Aim: Knowledge-focused
Last updated May 11, 2026 20:52 UTC